Article info
Cystic fibrosis
Original research
Longitudinal effects of ivacaftor and medicine possession ratio in people with the Gly551Asp mutation: a 5-year study
- Correspondence to Dr Peter J Barry, Manchester Adult Cystic Fibrosis Centre, Manchester University NHS Foundation Trust, Manchester, UK; peter.barry{at}mft.nhs.uk
Citation
Longitudinal effects of ivacaftor and medicine possession ratio in people with the Gly551Asp mutation: a 5-year study
Publication history
- Received June 17, 2020
- Revised December 28, 2020
- Accepted January 19, 2021
- First published February 12, 2021.
Online issue publication
August 13, 2021
Article Versions
- Previous version (12 February 2021).
- Previous version (25 March 2021).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.